SNBL - A Leading Company in Nasal Drug Delivery

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD  NDS DIVISION

Effective, Easy-to-use

BUSINESS

BUSINESS

Nasal Delivery System (NDS) Division develops novel nasal drug delivery technologies in collaboration with Shin Nippon Biomedical Laboratories (SNBL) Contract Research Division.

RESEARCH & DEVELOPMENT

RESEARCH & DEVELOPMENT

μco™ System is an innovative nasal drug delivery system, consisting of a novel nasal carrier and novel nasal drug delivery devices.

DEVELOPMENT PIPELINE

DEVELOPMENT PIPELINE

NDS Division has a pipeline of nasal drug products under development.The goal is to establish strategic partnerships with pharmaceutical companies through out-licensing product candidates.

PARTNERING

PARTNERING

NDS Division’s nasal drug products and the platform nasal delivery system (μco™ System), are available for out-licensing. NDS Division provides feasibility study programs to assess the suitability and advantages of using μco™ System with new or existing compounds.